Mercado mundial de tratamiento del neuroma de Morton: tendencias de la industria y pronóstico hasta 2030

Análisis y tamaño del mercado de tratamiento del neuroma de Morton         

El neuroma de Morton afecta la parte anterior del pie y es una enfermedad benigna pero dolorosa. También se lo conoce como neuroma intermetatarsiano porque se encuentra entre los huesos metatarsianos en la parte anterior del pie. Es una enfermedad que afecta a uno de los nervios digitales plantares, que recorren los huesos largos del pie (metatarsianos). El nervio entre el tercer y cuarto hueso metatarsiano es el más afectado, lo que provoca dolor y entumecimiento en el tercer y cuarto dedo del pie. También puede causar problemas en el segundo y tercer dedo del pie al afectar el nervio entre el segundo y tercer hueso metatarsiano. Afecta principalmente a personas de mediana edad, en su mayoría mujeres. Los zapatos demasiado ajustados o con tacones altos son con frecuencia la causa del neuroma de Morton. Los nervios de los pies pueden aplastarse o irritarse debido al uso de estos zapatos. Como resultado de la tensión en el nervio irritado, este se engrosa y se vuelve cada vez más doloroso.

Data Bridge Market Research analiza que el mercado global de tratamiento del neuroma de Morton, que fue de USD 474,00 millones en 2022, alcanzará los USD 716,63 millones para 2030 y se espera que experimente una CAGR del 4,70% durante el período de pronóstico. La "medicación" domina el segmento de tratamiento del mercado de tratamiento del neuroma de Morton debido a los prometedores efectos terapéuticos producidos por la medicación. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología de pacientes, análisis de la cartera de proyectos, análisis de precios y marco regulatorio.

Alcance del informe y segmentación del mercado

Market Definition

Morton's neuroma is a painful foot condition characterized by the thickening of the tissue surrounding a nerve, commonly between the third and fourth toes. This condition is often associated with irritation or compression of the nerve, frequently caused by wearing tight or high-heeled shoes. Symptoms include sharp, burning pain in the ball of the foot, numbness, tingling, and the sensation of a lump or object inside the shoe. The pain may radiate into the toes, and symptoms may worsen during activities that put pressure on the forefoot. Diagnosis involves a physical examination and may include imaging studies. Treatment options range from conservative measures like footwear adjustments and orthotics to more invasive interventions, including corticosteroid injections or surgery in severe cases.

Global Morton’s Neuroma Treatment Market Dynamics

Drivers

• Increasing incidence and prevalence

The growing occurrence of Morton's neuroma, attributed to factors like lifestyle changes and aging, acts as a primary driver. As more individuals experience symptoms, there is a rising demand for effective treatment options. This trend emphasizes the need for accessible and advanced healthcare solutions to address the increasing prevalence of this foot condition.

• Aging population

The demographic shift toward an aging population significantly contributes to the demand for Morton's neuroma treatments. As individuals age, the risk of foot-related issues, including neuromas, rises. This demographic trend underscores the importance of developing targeted and efficient treatments to address the specific needs and challenges associated with Morton's neuroma in older adults.

Opportunities

• Advancements in medical technology

The growth of the Morton's neuroma treatment market is likely to spur advancements in medical technology, particularly in diagnostic tools and imaging techniques. Innovations such as high-resolution ultrasound or magnetic resonance imaging (MRI) may provide more accurate and detailed insights into neuroma conditions, enabling healthcare professionals to tailor treatment plans based on precise diagnostic information.

• Expanded therapeutic options

Increasing market demand offers an opportunity for the development and introduction of a diverse range of therapeutic options. This may encompass pharmacological interventions, physical therapies, and non-invasive approaches, providing a broader spectrum of choices for patients and healthcare providers. The expansion of therapeutic options aligns with the goal of tailoring treatments to individual patient needs and preferences, enhancing overall effectiveness and patient satisfaction.

Restraints/Challenges

• Limited non-invasive treatment options

The availability of non-invasive treatment options for Morton's neuroma is somewhat limited. While conservative measures such as footwear modification and orthotics are common, more advanced cases may require invasive interventions, including surgical procedures. The preference for non-invasive solutions can be a challenge for individuals seeking effective yet minimally disruptive treatments.

• Diagnostic challenges

Diagnosing Morton's neuroma can be challenging, as symptoms may overlap with other foot conditions. Achieving a precise diagnosis often requires a combination of clinical evaluation and imaging studies. The need for accurate and timely diagnosis presents a challenge in ensuring appropriate and targeted treatment plans.

This Morton’s neuroma treatment Market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Morton’s neuroma treatment Market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Morton’s neuroma treatment Market Scope

The Morton’s neuroma treatment Market is segmented on the basis of treatment, diagnosis, dosage, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Medication
• Injection Therapy
• Surgery
• Others

Diagnosis

• Physical Examination
• Magnetic Resonance Imaging (MRI)
• X-Ray
• Ultrasound
• Others

Dosage

• Injection
• Tablets
• Others

Route of Administration

• Oral
• Parenteral
• Others

End Users

• Clinic
• Hospital
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Morton’s Neuroma Treatment Market Regional Analysis/Insights

The Morton’s neuroma treatment Market is analyzed and market size insights and trends are provided by country, treatment, diagnosis, dosage, route of administration, end users and distribution channel as referenced above.

The countries covered in the Morton’s neuroma treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the Morton’s neuroma treatment market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region.

Asia-Pacific is expected to grow during the forecast period due to the increasing patient pool, rising investment in the healthcare sector, and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The Morton’s neuroma treatment Market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Morton’s neuroma treatment Market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Morton’s neuroma treatment Market. The data is available for historic period 2010-2020.

Competitive Landscape and Morton’s Neuroma Treatment Market Share Analysis

El panorama competitivo del mercado de tratamiento del neuroma de Morton proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento del producto, la amplitud y la variedad del producto, el dominio de la aplicación. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas relacionado con el mercado de tratamiento del neuroma de Morton.

Algunos de los principales actores que operan en el mercado de tratamiento del neuroma de Morton son:

• Pfizer Inc. (Estados Unidos)
• GlaxoSmithKline plc (Reino Unido)
• Novartis AG (Suiza)
• Sanofi (Francia)
• Abbott (Estados Unidos)
• Bayer AG (Alemania)
• Johnson & Johnson Private Limited (Estados Unidos)
• Boehringer Ingelheim International GmbH (Alemania)
• AstraZeneca (Reino Unido)
• Assertio Holdings, Inc. (Estados Unidos)
• Horizon Therapeutics plc (Irlanda)
• Perrigo Company plc (Irlanda)
• F. Hoffmann-La Roche Ltd. (Suiza)
• Mylan NV (Estados Unidos)
• Allergan (Irlanda)
• Merck & Co., Inc. (Estados Unidos)
• Industrias farmacéuticas Sun Ltd. (India)
• Aurobindo Pharma (India)
• Lupino (India)
• AbbVie Inc. (Estados Unidos)
• Eli Lilly and Company (Estados Unidos)
• Cipla Inc. (India)

SKU-67540